Literature DB >> 2334301

Seizure risk with recurrent alcohol detoxification.

R Lechtenberg1, T M Worner.   

Abstract

To determine if there is an increase in the risk of seizure activity when patients experience recurrent alcohol detoxifications, we reviewed the detoxification and seizure histories of 256 men and 45 women voluntarily admitted to a 5-day in-patient detoxification program. Structural brain damage, focal neurologic deficits, epileptogenic findings on electroencephalograms, and provocative drug use were all considered pertinent variables for seizure risk. Seizures did not occur during alcohol detoxification in any of the study patients, despite a high incidence of antecedent seizures and provocative drug use. Oral chlordiazepoxide use during detoxification was associated with the elimination of withdrawal seizures. Of all 301 patients, 64 had a history of seizures, 42 had significantly abnormal electroencephalograms during detoxification, and 30 had focal slowing on the electroencephalogram. There was no correlation between the duration of alcohol abuse or lifetime consumption of alcohol and seizure activity. There was, however, a significant correlation between the number of inpatient alcohol detoxifications and the prevalence of seizure disorders. This correlation held true even when provocative drug use was taken into consideration.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2334301     DOI: 10.1001/archneur.1990.00530050055012

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  11 in total

Review 1.  Functional genomics strategies to identify susceptibility genes and treatment targets in alcohol dependence.

Authors:  Markus Heilig; Wolfgang Sommer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

2.  Ethosuximide Reduces Mortality and Seizure Severity in Response to Pentylenetetrazole Treatment During Ethanol Withdrawal.

Authors:  Melissa A Riegle; Melissa L Masicampo; Hong Qu Shan; Victoria Xu; Dwayne W Godwin
Journal:  Alcohol Alcohol       Date:  2015-04-12       Impact factor: 2.826

Review 3.  Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action.

Authors:  Philippe De Witte; John Littleton; Philippe Parot; George Koob
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 4.  Emergency management of acute alcohol problems. Part 2: Alcohol-related seizures, delirium tremens, and toxic alcohol ingestion.

Authors:  J M Etherington
Journal:  Can Fam Physician       Date:  1996-12       Impact factor: 3.275

5.  Utilization of acute inpatient services for alcohol detoxification.

Authors:  B M Booth; F C Blow; R L Ludke; R L Ross
Journal:  J Ment Health Adm       Date:  1996

Review 6.  Conceptual framework for the etiology of alcoholism: a "kindling"/stress hypothesis.

Authors:  George R Breese; David H Overstreet; Darin J Knapp
Journal:  Psychopharmacology (Berl)       Date:  2004-10-23       Impact factor: 4.530

Review 7.  Managing alcohol withdrawal in the elderly.

Authors:  K L Kraemer; J Conigliaro; R Saitz
Journal:  Drugs Aging       Date:  1999-06       Impact factor: 3.923

8.  Reinstatement of ethanol-seeking behavior by drug cues following single versus multiple ethanol intoxication in the rat: effects of naltrexone.

Authors:  Roberto Ciccocioppo; Daniel Lin; Rémi Martin-Fardon; Friedbert Weiss
Journal:  Psychopharmacology (Berl)       Date:  2003-03-27       Impact factor: 4.530

Review 9.  Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management.

Authors:  Matti Hillbom; Ilkka Pieninkeroinen; Maurizio Leone
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

10.  Ethosuximide reduces electrographical and behavioral correlates of alcohol withdrawal seizure in DBA/2J mice.

Authors:  Melissa A Riegle; Melissa L Masicampo; Erin H Caulder; Dwayne W Godwin
Journal:  Alcohol       Date:  2014-05-04       Impact factor: 2.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.